Free Trial

CureVac (CVAC) Earnings Date, Estimates & Call Transcripts

CureVac logo
$2.47 -0.02 (-0.80%)
(As of 10:25 AM ET)

CureVac Latest Earnings Summary

Upcoming Q3
Earnings Date
Apr. 23Estimated
Actual EPS
(Aug. 15)
-$0.34 Missed By -$0.06
Consensus EPS
(Aug. 15)
-$0.28

CureVac announced Q2 2024 earnings on August 15, 2024, reporting an EPS of -$0.34, which missed the consensus estimate of -$0.28 by $0.06. Quarterly revenue was reported to be $15.55 million, above analyst estimates of $10.07 million. With a trailing EPS of $0.55 and a P/E Ratio of 4.49, CureVac's earnings are expected to decrease next year, from $0.61 to ($0.49) per share.

CVAC Upcoming Earnings

CureVac's next earnings date is estimated for Wednesday, April 23, 2025, based off prior year's reporting schedules.

Get CureVac Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CureVac and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

CVAC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CVAC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

CureVac Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.14-$0.14-$0.14
Q2 20241-$0.26-$0.26-$0.26
Q3 20241$1.65$1.65$1.65
Q4 20241-$0.28-$0.28-$0.28
FY 20244$0.97$0.97$0.97

CureVac Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
4/23/2025
(Estimated)
------- 
8/15/2024Q2 2024-$0.28-$0.34 -$0.06-$0.34$10.07M$15.55M
5/23/2024Q1 2024-$0.22-$0.34 -$0.12-$0.34$14.51M$13.43M
4/24/2024Q4 2023--$0.42 -$0.42-$0.42-$24.30M  
11/14/2023Q3 2023-$0.26-$0.24+$0.02-$0.24$15.01M$17.94M        
8/17/2023Q2 2023-$0.28-$0.33 -$0.05-$0.33$14.89M$8.25M  
5/30/2023Q1 2023-$0.29-$0.29--$0.29$16.45M$7.65M  

CureVac Earnings - Frequently Asked Questions

CureVac has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 23rd, 2025 based off last year's report dates. Learn more on CVAC's earnings history.

In the previous quarter, CureVac (NASDAQ:CVAC) missed the analysts' consensus estimate of ($0.28) by $0.06 with a reported earnings per share (EPS) of ($0.34). Learn more on analysts' earnings estimate vs. CVAC's actual earnings.

CureVac (NASDAQ:CVAC) has a recorded annual revenue of $58.18 million.

CureVac (NASDAQ:CVAC) has a recorded net income of -$281.58 million. CVAC has generated $0.55 earnings per share over the last four quarters.

CureVac (NASDAQ:CVAC) has a trailing price-to-earnings ratio of 4.53 and a forward price-to-earnings ratio of 4.08. The price/earnings-to-growth ratio is 0.21.

CureVac's earnings are expected to decrease from $0.61 per share to ($0.49) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:CVAC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners